We are live on ! Find out more
JY

Jeff Yass Susquehanna International Group

AUM $1.28T
1-Year Est. Return 58.89%
 

Jeff Yass is a co-founder of Susquehanna International Group (SIG), a major global trading and market-making firm. SIG is known for options expertise, quantitative trading, and a training culture grounded in probabilistic decision-making. Yass’s firm is influential across derivatives markets even though it is less of a traditional long-only stock-picking franchise.

This Fund
S&P 500
This Quarter Est. Return
-5.25%
1 Year Est. Return
+58.89%
3 Year Est. Return
+161.44%
5 Year Est. Return
+153.95%
10 Year Est. Return
+561.69%
AUM
$578B
AUM Growth
-$88.6B
Cap. Flow
-$42.9B
Cap. Flow %
-7.42%
Top 10 Hldgs %
34.17%
Holding
14,706
New
1,657
Increased
4,874
Reduced
6,001
Closed
1,835

Sector Composition

Rank Sector Weight
1 Technology 2.07%
2 Consumer Discretionary 1.49%
3 Financials 1.12%
4 Communication Services 1.1%
5 Healthcare 0.62%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
WKSP icon
14001
CALL
Worksport
WKSP
$9M
-5,080
Closed -$123K
WLY icon
14002
John Wiley & Sons Class A
WLY
$2.62B
-7,850
Closed -$412K
WMG icon
14003
PUT
Warner Music
WMG
$14.2B
-16,300
Closed -$704K
WOOD icon
14004
CALL
iShares Global Timber & Forestry ETF
WOOD
$270M
-6,700
Closed -$617K
WOOF icon
14005
Petco
WOOF
$811M
-231,961
Closed -$4.34M
WOW
14006
CALL
DELISTED
WideOpenWest
WOW
-74,800
Closed -$1.61M
WSR
14007
PUT
DELISTED
Whitestone REIT
WSR
-37,400
Closed -$379K
WT icon
14008
PUT
WisdomTree
WT
$3.56B
-94,600
Closed -$579K
FXHO
14009
UTime Limited
FXHO
$284M
0
-$42K
WTV icon
14010
WisdomTree US Value Fund
WTV
$3.3B
-11,362
Closed -$720K
WVE icon
14011
Wave Life Sciences
WVE
$1.04B
-16,670
Closed -$40.8K
XBAP icon
14012
Innovator US Equity Accelerated 9 Buffer ETF April
XBAP
$131M
-8,347
Closed -$229K
XBIO icon
14013
Xenetic Biosciences
XBIO
$8.41M
-12,711
Closed -$164K
XBIO icon
14014
PUT
Xenetic Biosciences
XBIO
$8.41M
-14,380
Closed -$186K
XBIT icon
14015
CALL
XBiotech
XBIT
$69.5M
-20,400
Closed -$227K
XBIT icon
14016
XBiotech
XBIT
$69.5M
-13,007
Closed -$145K
XDEC icon
14017
FT Vest US Equity Enhance & Moderate Buffer ETF December
XDEC
$203M
-7,860
Closed -$242K
XFOR icon
14018
CALL
X4 Pharmaceuticals
XFOR
$401M
-1,603
Closed -$110K
XHR
14019
CALL
Xenia Hotels & Resorts
XHR
$1.79B
-11,000
Closed -$199K
XPL icon
14020
Solitario Resources
XPL
$75.7M
-60,432
Closed -$30K
XPO icon
14021
XPO
XPO
$23.2B
-98,129
Closed -$4.1M
XRX icon
14022
Xerox
XRX
$381M
-97,375
Closed -$2.05M
XSHQ icon
14023
Invesco S&P SmallCap Quality ETF
XSHQ
$319M
-12,175
Closed -$477K
XSOE icon
14024
PUT
WisdomTree Emerging Markets ex-State-Owned Enterprises Fund
XSOE
$2.12B
-12,300
Closed -$453K
XTNT icon
14025
Xtant Medical Holdings
XTNT
$45.6M
-13,867
Closed -$8K

Similar funds

Jeff Yass's Q1 2022 Portfolio in Review

As of Q1 2022, Jeff Yass held 14,706 positions worth $578B, down 13% from $667B the previous quarter. Its ten largest holdings account for 34% of the portfolio.

Jeff Yass withdrew a net $42.9B in Q1 2022, closing 1,835 positions and reducing 6,001 holdings. Its most notable exit was Xilinx Inc, an estimated $217M position sold in full.

By sector, the portfolio is most concentrated in Technology at 2.1% of assets, up from 1.6% a quarter earlier, followed by Consumer Discretionary and Financials.

Against the trend, Jeff Yass opened a new position in iShares JPMorgan USD Emerging Markets Bond ETF worth $107M.

  • Jeff Yass's largest Q1 2022 buy was iShares JPMorgan USD Emerging Markets Bond ETF: 1,089,723 shares worth $107M.
  • Jeff Yass added most to State Street SPDR S&P 500 ETF Trust in Q1 2022, an estimated $1.98B increase.
  • Jeff Yass's biggest Q1 2022 reduction was Walt Disney, cutting an estimated $498M.
  • Jeff Yass fully exited Xilinx Inc in Q1 2022, selling an estimated $217M.
  • Jeff Yass's ten largest holdings make up 34% of its $578B portfolio in Q1 2022.
  • Jeff Yass opened 1,657 new positions and closed 1,835 in Q1 2022.
  • Jeff Yass's portfolio value fell 13% quarter-over-quarter to $578B.

Based on Susquehanna International Group's 13F filing for Q1 2022, filed 16 May 2022.